Vaxinano
The startup specializes in the development of prophylactic and therapeutic vaccines for infectious diseases using safe-by-design nanoparticles that comply with green chemistry principles. By providing support in the formulation of drugs for active biomolecules, proteins, and antigens, the company enables medical researchers to create vaccines for viral, bacterial, and parasitic diseases that currently lack effective treatments.
- Biotechnology
Updated 5 months ago
Funding
Raised to date
$8.2MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup specializes in the development of prophylactic and therapeutic vaccines for infectious diseases using safe-by-design nanoparticles that comply with green chemistry principles. By providing support in the formulation of drugs for active biomolecules, proteins, and antigens, the company enables medical researchers to create vaccines for viral, bacterial, and parasitic diseases that currently lack effective treatments.